Valuation: AstraZeneca PLC

Market Cap 277B 243B 224B 207B 393B 26,487B 400B 2,681B 1,051B 13,007B 1,042B 1,019B 45,055B P/E 2026 *
22.4x
P/E 2027 * 19.8x
Enterprise Value 297B 260B 239B 222B 421B 28,335B 428B 2,868B 1,124B 13,914B 1,114B 1,090B 48,197B EV / Sales 2026 *
4.7x
EV / Sales 2027 * 4.34x
Free-Float
96.63%
Yield 2026 *
1.86%
Yield 2027 * 1.97%

Last Transcript: AstraZeneca PLC

1 day-1.49%
1 week-9.07%
Current month-6.77%
1 month-2.37%
3 months-13.69%
6 months-6.90%
Current year-4.68%
1 week 12,388
Extreme 12388
14,526
1 month 11,484
Extreme 11484
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,178
Extreme 10178
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jul. 05Free

See Remarks

2 0.0000%
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-1.48%-9.07%+23.71%+29.13% 277B
+0.09%+0.25%+54.65%+169.19% 1,085B
-1.63%-1.50%+65.79%+62.70% 624B
-1.12%-4.27%+31.10%+84.44% 442B
+0.94%-0.56%+28.78%+27.69% 332B
+0.60%-2.19%+26.12%+45.86% 282B
+0.41%-1.70%-29.46%-39.47% 217B
-1.19%-2.81%+22.63%+66.30% 196B
-0.72%+2.72%+19.07%+81.19% 167B
+0.83%-0.29%-5.13%-31.75% 138B
Average -0.08%-1.71%+23.73%+49.53% 376.01B
Weighted average by Cap. +0.23%-1.03%+36.73%+80.81%

Financials

2026 *2027 *
Net sales 63.15B 55.25B 50.95B 47.14B 89.47B 6,028B 90.97B 610B 239B 2,960B 237B 232B 10,254B 66.74B 58.39B 53.84B 49.82B 94.56B 6,371B 96.14B 645B 253B 3,128B 251B 245B 10,837B
Net income 12.44B 10.88B 10.03B 9.28B 17.62B 1,187B 17.92B 120B 47.11B 583B 46.69B 45.68B 2,020B 13.86B 12.13B 11.18B 10.35B 19.64B 1,323B 19.97B 134B 52.5B 650B 52.04B 50.91B 2,251B
Net Debt 19.35B 16.93B 15.61B 14.45B 27.42B 1,847B 27.88B 187B 73.29B 907B 72.65B 71.08B 3,142B 12.17B 10.65B 9.82B 9.09B 17.25B 1,162B 17.53B 118B 46.1B 571B 45.7B 44.71B 1,976B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-10 GBX 13,149.00 -1.54% 432,446
26-07-09 GBX 13,354.00 -6.22% 7,624,478
26-07-08 GBX 14,240.00 -0.86% 1,480,149
26-07-07 GBX 14,364.00 +1.87% 1,528,247
26-07-06 GBX 14,100.00 -2.46% 2,008,204
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
178.91USD
Average target price
215.39USD
Spread / Average Target
+20.39%

Quarterly revenue - Rate of surprise